Daniel Passeri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Passeri
Earlier roles on record: Board Member and CEO at Cue Biopharma, Inc. (CUE) until September 29, 2025. Cue Biopharma, Inc. reported in an 8-K filed September 29, 2025 that Daniel Passeri resigned as member of the Board, effective September 29, 2025. Cue Biopharma, Inc. reported in an 8-K filed September 29, 2025 that Daniel Passeri retired as Chief Executive Officer, effective September 29, 2025. The proxy statement of Cue Biopharma, Inc. reports total compensation of $1,426,183 for Daniel Passeri in fiscal 2025, including a base salary of $240,504. Disclosed compensation is on record for 8 fiscal years. Daniel Passeri has spoken on 5 earnings calls across 1 company, most recently for Cue Biopharma, Inc. on June 30, 2024.
“Dr. Azam will succeed Daniel R. Passeri whose retirement and resignation as Chief Executive Officer and as a member of the Board will be effective as of the Effective Date.”
“Dr. Azam will succeed Daniel R. Passeri whose retirement and resignation as Chief Executive Officer and as a member of the Board will be effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-09-29
-
Start not stated–2025-09-29
-
Start not stated–2025-09-29
-
Start not stated–2025-09-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $240,504 | $1,426,183 |
| 2024 | Cue Biopharma, Inc. (CUE) | Former Chief Executive Officer | $492,910 | $1,393,921 |
| 2023 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $604,824 | $3,015,480 |
| 2022 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $747,507 | $1,373,850 |
| 2021 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $530,974 | $1,820,756 |
| 2020 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $501,154 | $5,841,786 |
| 2019 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $395,000 | $1,198,614 |
| 2018 | Cue Biopharma, Inc. (CUE) | Chief Executive Officer | $345,000 | $833,858 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.